Othmar Zenker

Othmar Zenker

UNVERIFIED PROFILE

Are you Othmar Zenker?   Register this Author

Register author
Othmar Zenker

Othmar Zenker

Publications by authors named "Othmar Zenker"

Are you Othmar Zenker?   Register this Author

6Publications

63Reads

Longitudinal changes in measles antibody titers in plasma donors and minimum antibody levels of immunoglobulin products for treatment of primary immunodeficiency.

Authors:
Toby L Simon Peter FitzGerald Mirjam Kühne Connie Farrar Jonathan Knowles Keith Bycholski Othmar Zenker

Transfusion 2018 Dec;58 Suppl 3:3065-3071

InflaRx, Jena, Germany.

View Article
December 2018

Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).

Authors:
Jean-Marc Léger Jan L De Bleecker Claudia Sommer Wim Robberecht Mika Saarela Jerzy Kamienowski Zbigniew Stelmasiak Orell Mielke Björn Tackenberg Amgad Shebl Artur Bauhofer Othmar Zenker Ingemar S J Merkies

J Peripher Nerv Syst 2013 Jun;18(2):130-40

Reference Center for Rare Neuromuscular Diseases, Hôpital Pitié-Salpêtrière and University Paris VI, Paris, France.

View Article
June 2013

Efficacy and safety of hizentra®, a new 20% immunoglobulin preparation for subcutaneous administration, in pediatric patients with primary immunodeficiency.

Authors:
Michael Borte Malgorzata Pac Margit Serban Teresa Gonzalez-Quevedo Bodo Grimbacher Stephen Jolles Othmar Zenker Jutta Neufang-Hueber Bernd Belohradsky

J Clin Immunol 2011 Oct 15;31(5):752-61. Epub 2011 Jun 15.

Hospital St. Georg GmbH Leipzig, Academic Teaching Hospital of the University of Leipzig, Delitzscher Strasse 141, 04129, Leipzig, Germany.

View Article
October 2011

Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies.

Authors:
Melvin Berger Mikhail Rojavin Peter Kiessling Othmar Zenker

Clin Immunol 2011 May 23;139(2):133-41. Epub 2011 Jan 23.

Immunology Research and Development, CSL Behring, King of Prussia, PA 19406-0901, USA.

View Article
May 2011

Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency.

Authors:
John B Hagan Mary B Fasano Sheldon Spector Richard L Wasserman Isaac Melamed Mikhail A Rojavin Othmar Zenker Jordan S Orange

J Clin Immunol 2010 Sep 8;30(5):734-45. Epub 2010 May 8.

Division of Allergic Diseases, Mayo Clinic, 200 First St. S.W., Rochester, MN 55905, USA.

View Article
September 2010

Carimune NF Liquid is a safe and effective immunoglobulin replacement therapy in patients with primary immunodeficiency diseases.

Authors:
Melvin Berger Charlotte Cunningham-Rundles Francisco A Bonilla Isaac Melamed Johann Bichler Othmar Zenker Mark Ballow

J Clin Immunol 2007 Sep 4;27(5):503-9. Epub 2007 May 4.

Rainbow Babies and Children's Hospital, Division of Allergy/Immunology, 111100 Euclid Avenue, Cleveland, Ohio 44106, USA.

View Article
September 2007